News | EP Mapping and Imaging Systems | October 06, 2015

AcQMap System Shows Improved 3-D Mapping Over CT During AFib Ablation

Technology demonstrates higher resolution, faster mapping times during treatment of cardiac arrhythmias

Acutus Medical, AcQMap High Resolution Imaging and Mapping System, improvement over sCT

Image courtesy of Acutus Medical

October 6, 2015 — Acutus Medical, a global heart rhythm technology company, presented data that show the AcQMap High Resolution Imaging and Mapping System more rapidly and clearly maps atrial fibrillation (AF) than segmented computed tomography (sCT) mapping, the current standard for most AF ablation procedures.  The initial study findings were presented during an oral presentation at the 10th annual Heart Rhythm Congress held in Birmingham, United Kingdom, Oct. 4-7, 2015.

The abstract titled, “Novel Global Ultrasound Imaging And Continuous Dipole Density Mapping: Initial Findings In AF Patients” was presented by Patrick Heck, M.D., Ph.D, Papworth Hospital, Cambridge, UK. The study evaluated the difference in mapping clarity and detection time between the AcQMap System and sCT in six patients diagnosed with complex arrhythmias. The findings concluded that the AcQMap System reconstructed an image of the atrium at 4.1 times higher resolution than that of sCT. The System also detected the arrhythmia more quickly than sCT (4:07 minutes versus 6:39 minutes, respectively).

“These data underscore the potential advantage the AcQMap System can provide to electrophysiologists (EPs) during AF procedures compared to current standards of mapping technology,” said Heck.  “The image quality of the AcQMap System is unparalleled and allows EPs to see areas of the heart chamber we’ve never been able to visualize before. This is an impressive leap forward, truly opening the possibility to map AF with more precision to identify areas of interest as potential ablation targets.”

The AcQMap System can generate real-time ultrasound images of the heart chamber with quality equivalent to a CT or magnetic resonance image (MRI) in a matter of minutes. The system is the first and only to detect and display both the standard voltage-based maps as well as the higher resolution source charge (dipole density) maps through a proprietary algorithm. The result of combining highly accurate imaging with higher resolution mapping capabilities enables EPs to identify and locate the responsible charge for the arrhythmia, precisely target treatment areas and minimize unnecessary heart ablations.

For more information: www.acutusmedical.com

Related Content

 ElectroSonix
News | EP Lab | December 30, 2019
December 30, 2019 — Acoustoelectric cardiac imaging, a new, noninvasive cardiac imaging technology developed at the U
Peter_Weiss, M.D., explains a Stereotaxis robotically navigated cardiac ablation procedure at Banner University Medicine Heart Institute.

Peter_Weiss, M.D., explains a Stereotaxis robotically navigated cardiac ablation procedure at Banner University Medicine Heart Institute.

Feature | EP Lab | December 23, 2019 | J. Peter Weiss, M.D., MSc
Robotic technology, which helps carry out repetitive tasks efficiently and precisely, has been gaining ground in...
Earlier this year, Medtronic began a worldwide pivotal study evaluating its investigational Extravascular Implantable Cardioverter Defibrillator (EV ICD) system to treat dangerously fast heart rhythms. The EV ICD system is designed to deliver lifesaving defibrillation and pacing therapy via a device the same size as traditional, transvenous ICDs, but with a lead (thin wire) placed outside the heart and veins. The future of CRM device technology.

Earlier this year, Medtronic began a worldwide pivotal study evaluating its investigational Extravascular Implantable Cardioverter Defibrillator (EV ICD) system to treat dangerously fast heart rhythms. The EV ICD system is designed to deliver lifesaving defibrillation and pacing therapy via a device the same size as traditional, transvenous ICDs, but with a lead (thin wire) placed outside the heart and veins.

Feature | EP Lab | November 11, 2019 | Hrishikesh Kadam
Cardiac rhythm management (CRM) devices in use today are evolving to raise the bar beyond monitoring and managing car
A comparison between the EPstar 2F and 6F catheters from Baylis. Electrophysiology catheters. EP lab

A comparison between the EPstar 2F and 6F catheters from Baylis.

News | EP Lab | October 31, 2019
October 31, 2019 — Baylis Medical announced the first North American use of its EPstar Fixed...
New Study Shows Chronic Epilepsy Associated With Marker of Cardiac Electrical Instability
News | EP Lab | October 24, 2019
LivaNova PLC announced the publication of a new study in Neurology, which suggests that chronic epilepsy may be...
Lenox Hill Hospital Opens New Heart Rhythm Center
News | EP Lab | August 27, 2019
Lenox Hill Hospital (New York, N.Y.) has established a brand new Heart Rhythm Center dedicated to the treatment of...
Damaged Hearts Rewired With Nanotube Fibers

Researchers at Texas Heart Institute and Rice University have confirmed that flexible, conductive fibers made of carbon nanotubes can bridge damaged tissue to deliver electrical signals and keep hearts beating despite congestive heart failure or dilated cardiomyopathy or after a heart attack. Image courtesy of Texas Heart Institute.

News | EP Lab | August 15, 2019
Thin, flexible fibers made of carbon nanotubes have now proven able to bridge damaged heart tissues and deliver the...
Cardiac Device Complications Vary Widely Among Hospitals
News | EP Lab | July 31, 2019
The chances of patients experiencing complications after having a cardiac device implanted vary according to where they...
Overlay Init